Subscribe to RSS - consent decree

consent decree

Change of focus drives improvements at Invacare

‘We are really not about the consent decree,’ top exec tells investors

ELYRIA, Ohio – Invacare is holding tight to an improvement in gross margin for its beleaguered North America HME division as a sign that its turnaround efforts are paying off.

Invacare readies to submit final report to FDA


ELYRIA, Ohio – Invacare could be turning the corner on its “ongoing journey” to lift a consent decree with the Food and Drug Administration that has handicapped the company since late 2012.

Invacare auditor submits third report


ELYRIA, Ohio – Invacare’s independent auditor this week issued its certification report for the third phase of the consent decree indicating substantial compliance to the FDA’s quality system regulation.

Invacare receives feedback from FDA


ELYRIA, Ohio – Invacare has received observations from the FDA following an inspection of its corporate headquarters and Taylor Street manufacturing facility.

Invacare ends year with losses


ELYRIA, Ohio – Invacare reported a net loss of $9.39 million for the fourth quarter ended Dec. 31, 2014, compared to a net loss of $5.77 million for the same period in 2013.

The company reported net sales of $318.2 million vs. $330.8 million.

Invacare puts ‘turnaround plan’ in motion


ELYRIA, Ohio – With a consent decree with the U.S. Food and Drug Administration (FDA) taking longer than it expected to resolve, Invacare has accelerated efforts to reduce its cost structure by reducing its workforce by 190 employees.

Invacare’s sales slump continues


ELYRIA, Ohio – Invacare ended the year the same way it started—hamstrung by a consent decree with the U.S. Food and Drug Administration (FDA) that has limited manufacturing at its Taylor Street facility.

Invacare’s sales take hit

Company blames consent decree, lack of new products

ELYRIA, Ohio – Invacare’s net sales for the year ended Dec. 31 fell 5.6% to $1.35 billion, the company has announced.

Invacare amends credit agreement


ELYRIA, Ohio – Invacare has amended its credit agreement, giving the company more flexibility on its maximum leverage ratio financial covenant through Sept. 30, 2014, according to an announcement.

Update: Third-party auditor delays Invacare’s progress

Company expects re-audit in February

ELYRIA, Ohio – Invacare has more work to do before it submits a final audit to the U.S. Food and Drug Administration (FDA) for approval.